March 10, 2022
Tarsus to Present at Upcoming Investor Conferences
IRVINE, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…
Pharmaceuticals, Biotechnology and Life Sciences
Author: GlobeNewswire
March 10, 2022
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2021
MISSISSAUGA, Ontario, March 09, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
March 10, 2022
NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Clinical data updates for the Company’s two lead product candidates in Phase 1/2 clinical trials expected in 2H22Investigational New Drug…
March 10, 2022
Bioasis to Attend and Present at Upcoming Industry Conference
NEW HAVEN, Conn., March 09, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…
March 10, 2022
Madrigal Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
CONSHOHOCKEN, Pa., March 09, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics…
March 10, 2022
DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document
Montrouge, France, March 9, 2022 DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration…
March 10, 2022
RVL Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2022
BRIDGEWATER, N.J., March 09, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical…
March 10, 2022
Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference
SEATTLE, March 09, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered…
March 10, 2022
Turning Point Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation…
March 10, 2022
BioVie to Participate at the Oppenheimer Virtual Annual Healthcare Conference
RENO, Nev., March 09, 2022 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing…